Neighborhood poverty and injection cessation in a sample of injection drug users

American Journal of Epidemiology

Volumn 171, Issue 4, 2010, Pages 391-398

  Nandi, Arijit ^a,b   Glass, Thomas A ^b   Cole, Stephen R ^c   Chu, Haitao ^c   Galea, Sandro ^d   Celentano, David D ^b   Kirk, Gregory D ^b   Vlahov, David ^e   Latimer, William W ^b   Mehta, Shruti H ^b  

^a HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c IL   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Drug users; Epidemiologic methods; Heroin; Poverty; Residence characteristics; Social environment; Substance related disorders

Indexed keywords

DIAMORPHINE;

DRUG USER; EPIDEMIOLOGY; NEIGHBORHOOD; POVERTY; SOCIOECONOMIC STATUS; SPATIOTEMPORAL ANALYSIS;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; MALE; POVERTY; SOCIAL ENVIRONMENT; SOCIOECONOMICS;

ADOLESCENT; ADULT; CONFOUNDING FACTORS (EPIDEMIOLOGY); DRUG USERS; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MARYLAND; POVERTY AREAS; PROBABILITY; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

BALTIMORE; MARYLAND; UNITED STATES;

EID: 76649083571     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp416     Document Type: Article

References (53)

1. Aceijas C, Stimson GV, Hickman M, et al. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18(17):2295-2303.
2. Morison L. The global epidemiology of HIV/AIDS. Br Med Bull. 2001;58:7-18.
3. Santibanez SS, Garfein RS, Swartzendruber A, et al. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006;83(1):86-100.
4. Friedman SR, Tempalski B, Cooper H, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81(3):377-400.
5. Friedman SR, Lieb S, Tempalski B, et al. HIVamong injection drug users in large US metropolitan areas, 1998. J Urban Health. 2005;82(3):434-445.
6. Bruneau J, Brogly SB, Tyndall MW, et al. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction. 2004;99(6):727-737.
7. Huo D, Bailey SL, Ouellet LJ. Cessation of injection drug use and change in injection frequency: the Chicago Needle Exchange Evaluation Study. Addiction. 2006;101(11):1606-1613.
8. Shah NG, Galai N, Celentano DD, et al. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend. 2006;83(2):147-156.
9. Steensma C, Boivin JF, Blais L, et al. Cessation of injecting drug use among street-based youth. J Urban Health. 2005; 82(4):622-637.
10. Latkin CA, Knowlton AR, Hoover D, et al. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am J Drug Alcohol Abuse. 1999;25(3):463-473.
11. Warner LA, Alegŕia M, Canino G. Remission from drug dependence symptoms and drug use cessation among women drug users in Puerto Rico. Arch Gen Psychiatry. 2004;61(10): 1034-1041.
12. Jacobson JO. Do drug treatment facilities increase clients' exposure to potential neighborhood-level triggers for relapse? A small-area assessment of a large, public treatment system. J Urban Health. 2006;83(2):150-161.
13. Wilson WJ. The Truly Disadvantaged. Chicago, IL: University of Chicago Press; 1987.
14. Wilson WJ. When Work Disappears. New York, NY: Random House; 1996.
15. Kasarda JD. Urban industrial transition and the underclass. Ann Am Acad Pol Soc Sci. 1989;501:26-47.
16. Sassen S. Economic restructuring and the American city. Annu Rev Sociol. 1990;16:465-490.
17. Bureau of the Census. Census summary tape, file 3A (STF 3A). Washington, DC: US Department of Commerce, 2000.
18. Bouhnik AD, Carrieri MP, Rey D, et al. Drug injection cessation among HIV-infected injecting drug users. Addict Behav. 2004;29(6):1189-1197.
19. Granfield R, Cloud W. Social context and "natural recovery": the role of social capital in the resolution of drug-associated problems. Subst Use Misuse. 2001;36(11):1543-1570.
20. Stephens RC. The Street Addict Role. Albany, NY: The State University of New York Press; 1991.
21. Diez Roux AV. Estimating neighborhood health effects: the challenges of causal inference in a complex world. Soc Sci Med. 2004;58(10):1953-1960.
22. Oakes JM. The (mis)estimation of neighborhood effects: causal inference for a practicable social epidemiology. Soc Sci Med. 2004;58(10):1929-1952.
23. Greenland S. Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology. 2003;14(3):300-306.
24. Cole SR, Hernán MA, Robins JM, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003;158(7):687-694.
25. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5): 561-570.
26. Hernán MA, Robins JM. Estimating causal effects from epi-demiological data. J Epidemiol Community Health. 2006; 60(7):578-586.
27. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560.
28. Sampson RJ, Sharkey P, Raudenbush SW. Durable effects of concentrated disadvantage on verbal ability among African-American children. Proc Natl Acad Sci USA. 2008;105(3): 845-852.
29. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75-100.
30. Bureau of the Census. Census summary tape, file 3A (STF 3A). Washington, DC: US Department of Commerce, 1990.
31. Krieger N, Chen JT, Waterman PD, et al. Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: the Public Health Disparities Geocoding Project. Am J Public Health. 2005;95(2):312-323.
32. Krieger N, Chen JT, Waterman PD, et al. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: The Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5): 471-482.
33. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002;14(5):367-378.
34. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152(2): 99-106.
35. Sherman SG, Hua W, Latkin CA. Individual and environmental factors related to quitting heroin injection. Subst Use Misuse. 2004;39(8):1199-1214.
36. Singer JD. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J Educ Behav Stat. 1998;23(4):323-355.
37. Galai N, Safaeian M, Vlahov D, et al. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: description and determinants. Am J Epidemiol. 2003; 158(7):695-704.
38. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008; 168(6):656-664.
39. Nandi A, Galea S, Ahern J, et al. What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City? Soc Sci Med. 2006;63(3): 662-674.
40. Williams CT, Latkin CA. Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. Am J Prev Med. 2007;32(6 suppl):S203-S210.
41. Wu ZH, Eschbach K, Grady JJ. Contextual influences on polydrug use among young, low-income women: effects of neighborhood and personal networks. Am J Addict. 2008; 17(2):135-144.
42. Maas B, Fairbairn N, Kerr T, et al. Neighborhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007;13(2):432-439.
43. Boardman JD, Finch BK, Ellison CG, et al. Neighborhood disadvantage, stress, and drug use among adults. J Health Soc Behav. 2001;42(2):151-165.
44. Crum RM, Lillie-Blanton M, Anthony JC. Neighborhood environment and opportunity to use cocaine and other drugs in late childhood and early adolescence. Drug Alcohol Depend. 1996;43(3):155-161.
45. Hacker MA, Leite IC, Renton A, et al. Reconstructing the AIDS epidemic among injection drug users in Brazil. Cad Saude Publica. 2006;22(4):751-760.
46. Kairouz S, Nadeau L, Siou GL. Area variations in the prevalence of substance use and gambling behaviours and problems in Quebec: a multilevel analysis. Can J Psychiatry. 2005; 50(10):591-598.
47. Latkin CA, Curry AD, Hua W, et al. Direct and indirect associations of neighborhood disorder with drug use and high-risk sexual partners. Am J Prev Med. 2007;32(6 suppl):S234-S241.
48. Schroeder JR, Latkin CA, Hoover DR, et al. Illicit drug use in one's social network and in one's neighborhood predicts individual heroin and cocaine use. Ann Epidemiol. 2001;11(6): 389-394.
49. Sunder PK, Grady JJ, Wu ZH. Neighborhood and individual factors in marijuana and other illicit drug use in a sample of low-income women. Am J Community Psychol. 2007;40(3-4): 167-180.
50. Latkin CA, Williams CT, Wang J, et al. Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychol. 2005; 24(1):96-100.
51. Cole SR, Hernán MA, Margolick JB, et al. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol. 2005; 162(5):471-478.
52. Hernán MA, Hernández-D́iaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15(5):615-625.
53. Robins JM, Greenland S. The role of model selection in causal inference from nonexperimental data. Am J Epidemiol. 1986; 123(3):392-402.